Dashboard
Manage Tickers

PFE


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

covid-19-patent-dispute-sorted-acuitas-therapeutics-and-curevac-reach-settlement-in-patent-battle
COVID-19 Patent Dispute Sorted: Acuitas Th...
04/26/2024 18:45:00

Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfi...

fda-green-lights-pfizers-gene-therapy-for-rare-bleeding-disorder-hemophilia
FDA Green Lights Pfizer's Gene Therapy For...
04/26/2024 18:30:08

FDA approves Pfizer's Beqvez for adults with hemophilia B, offering a one-time treatment to produce FIX. Experience reduced...

pfizers-options-a-look-at-what-the-big-money-is-thinking
Pfizer's Options: A Look at What the Big M...
04/26/2024 14:02:07

pfizer-says-us-fda-approved-companys-beqvez-fidanacogene-elaparvovec-dzkt-a-one-time-gene-therapy-for-adults-with-hemophilia-b-company-now-plans-launching-an-innovative-warranty-program-based-on-durability-of-patient-response-to-treatment
Pfizer Says U.S. FDA Approved Company's BE...
04/26/2024 10:48:48

With BEQVEZ now approved for use, Pfizer is launching an innovative warranty program based on durability of patient response to...

whats-going-on-with-pfizer-stock-on-thursday
What's Going On With Pfizer Stock On Thurs...
04/25/2024 17:51:32

GSK initiates legal proceedings against Pfizer and BioNTech over alleged COVID-19 vaccine patent infringement, intensifying hig...

wall-streets-most-accurate-analysts-views-on-3-health-care-stocks-delivering-high-dividend-yields
Wall Street's Most Accurate Analysts' View...
04/25/2024 11:54:20

pfizer-canada-says-health-canada-has-granted-a-notice-of-compliance-for-velsipity
Pfizer Canada Says Health Canada Has Grant...
04/24/2024 15:02:26

- Reuters

moderna-faces-pfizer-biontech-in-london-patent-battle-over-covid-19-vaccines-in-legal-showdown
Moderna Faces Pfizer, BioNTech in London P...
04/23/2024 19:00:34

Moderna challenges Pfizer and BioNTech in a London patent trial over mRNA vaccine patents. The outcome may reshape the pharmace...

pfizer-options-trading-a-deep-dive-into-market-sentiment
Pfizer Options Trading: A Deep Dive into M...
04/22/2024 15:31:36

european-commission-approves-pfizers-emblaveo-for-patients-with-multidrug-resistant-infections-and-limited-treatment-options
European Commission Approves Pfizer's EMBL...
04/22/2024 12:10:37

EMBLAVEO® is the first β-lactam/β-lactamase inhibitor antibiotic combination approved in the European Union for treating seriou...

cantor-fitzgerald-reiterates-overweight-on-pfizer-maintains-45-price-target
Cantor Fitzgerald Reiterates Overweight on...
04/18/2024 14:03:06

Cantor Fitzgerald analyst Louise Chen reiterates Pfizer (NYSE:PFE) with a Overweight and maintains $45 price target.

johnson--johnson-shows-focus-on-strengthening-its-business-upon-its-consumer-health-unit-spinoff
Johnson & Johnson Shows Focus On Strengthe...
04/16/2024 15:49:17

On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estima...

cantor-fitzgerald-reiterates-overweight-on-pfizer-maintains-45-price-target
Cantor Fitzgerald Reiterates Overweight on...
04/15/2024 14:33:14

Cantor Fitzgerald analyst Louise Chen reiterates Pfizer (NYSE:PFE) with a Overweight and maintains $45 price target.

a-closer-look-at-pfizers-options-market-dynamics
A Closer Look at Pfizer's Options Market D...
04/15/2024 13:46:56

wall-streets-most-accurate-analysts-views-on-3-health-care-stocks-with-over-3-dividend-yields
Wall Street's Most Accurate Analysts' View...
04/11/2024 11:48:46

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often com...

vaccine-player-vaxcyte-has-advantage-over-pfizer-mercks-pneumococcal-shots---analyst-says
Vaccine Player Vaxcyte Has Advantage Over ...
04/10/2024 18:42:39

The global PCV market, valued at ~$8 billion annually, is poised for significant growth, estimated to reach ~$12 billion soon. ...

the-pharmaceutical-industry-finds-itself-at-a-historical-crossroads
The Pharmaceutical Industry Finds Itself A...
04/10/2024 14:47:51

Bristol Myers Squibb (NYSE: BMY), Merck & Co Inc (NYSE: MRK), Pfizer Inc (NYSE: PFE) and Johnson & Johnson(NYSE:

pm-fumio-kishida-urges-us-tech-giants-to-invest-in-japan-im-strongly-promoting-policies-toward-the-next-economic-stage
PM Fumio Kishida Urges US Tech Giants To I...
04/10/2024 09:24:58

During a roundtable in Washington, Kishida highlighted the importance of U.S. investments in Japan, particularly in emerging te...

pfizer-seeks-expanded-use-of-abrysvo-as-vaccine-shows-potential-in-18-patients
Pfizer Seeks Expanded Use Of Abrysvo As Va...
04/09/2024 16:20:51

Discover pivotal Phase 3 trial results for Pfizer's Abrysvo vaccine in adults 18-59 at risk of severe RSV disease. Achieved...

decoding-pfizers-options-activity-whats-the-big-picture
Decoding Pfizer's Options Activity: What's...
04/09/2024 14:01:50

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION